programmed cell death protein
Influence of Schistosoma japonicum programmed cell death protein 10 on the growth and development of schistosomula
11
Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report
5
Immune checkpoint therapy in liver cancer
12
Immunotherapy for Merkel cell carcinoma: a turning point in patient care
6
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
7
Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
12
<p>Programmed cell death 1 expression and Epstein-Barr virus infection in chronic lymphocytic leukaemia: a prospective cohort study</p>
14
Programmed cell death and its role in inflammation
12
A Single Amino Acid Substitution in Obg Activates a New Programmed Cell Death Pathway in Escherichia coli
6
Programmed cell death in amyotrophic lateral sclerosis
10
Stretch induced programmed myocyte cell death
14
A comparison of programmed cell death between species
6
Ecdysone mediated programmed cell death in Drosophila
11
JNK-signaling: A multiplexing hub in programmed cell death
13
Programmed cell death in the developing kidney and the ubiquity of the programme
142
Programmed cell death in the developing limb
6
Molecular imaging biomarkers for cell based immunotherapies
7
The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis
14
<p>Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer</p>
16
Prediction of treatment responses to neoadjuvant chemotherapy in triple negative breast cancer by analysis of immune checkpoint protein expression
12